100
Participants
Start Date
October 31, 2009
Primary Completion Date
April 30, 2010
Xarlin (Levocetirizine)
Combination therapy compared to mono therapy
Cosalin (Petasites hybridus CO2 extract)
Combination therapy compared to mono therapy
Lead Sponsor
HK inno.N Corporation
INDUSTRY